It has been about a month since the last earnings report for Corcept Therapeutics (CORT). Shares have lost about 1.7% in that time frame, underperforming the S&P 500. Will the recent negative ...

Corcept Therapeutics (NASDAQ:CORT) said on Thursday that the mid-stage study of its cortisol modulator, dazucorilant, in patients with amyotrophic lateral sclerosis did not meet the main goal.

Corcept Therapeutics Incorporated engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Corcept Therapeutics Incorporated (NASDAQ:CORT) said on Thursday that it presented results from its Phase 2 DAZALS study of dazucorilant in patients with ALS at the European Network to Cure ALS ...

Juul de Cort Stilleven met kreeft en fazant op tafel met... Sale Date: March 9, 2020 Juul de Cort Sujets divers (8 works) Sale Date: March 26, 2013 Auction Closed Juul de Cort Stilleven in een ...

Visit a quote page and your recently viewed tickers will be displayed here.